Nov 7 (Reuters) - Endo International PLC ENDP.O :
* ENDO ANNOUNCES POSITIVE RESULTS FROM PHASE 3 STUDIES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) IN PATIENTS WITH CELLULITE
* ENDO INTERNATIONAL PLC - CCH WAS WELL-TOLERATED IN ACTIVELY-TREATED SUBJECTS
* ENDO INTERNATIONAL - BOTH RELEASE-1 AND RELEASE-2 STUDIES DEMONSTRATED HIGHLY STATISTICALLY SIGNIFICANT RESULTS ON EFFICACY ENDPOINTS
* ENDO INTERNATIONAL PLC - ANNOUNCED POSITIVE RESULTS TODAY FROM TWO IDENTICAL PHASE 3 RELEASE* STUDIES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM